Adiponectin receptors form homomers and heteromers exhibiting distinct ligand binding and intracellular signaling properties

Journal of Biological Chemistry

Volumn 288, Issue 5, 2013, Pages 3112-3125

  Almabouada, Farid ^a,b   Diaz Ruiz, Alberto ^a,b   Rabanal Ruiz, Yoana ^a,b   Peinado, Juan R ^c   Vazquez Martinez, Rafael ^a,b   Malagon, Maria M ^a,b  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASE; C TERMINUS; CO-TRANSFECTIONS; COLOCALIZE; CYTOSOLIC; ENDOPLASMIC RETICULUM; EXPRESSION LEVELS; EXTRACELLULAR; G-PROTEIN COUPLED RECEPTORS; HETEROMERIC COMPLEXES; IMMUNOPRECIPITATIONS; INTERACTION BEHAVIOR; INTRACELLULAR SIGNALING; ISOFORMS; LIGAND BINDING; OLIGOMERIZATION PATTERNS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; TRANS-MEMBRANE DOMAINS;

ACTIVATION ANALYSIS; CELL MEMBRANES; CYTOLOGY; ENZYME ACTIVITY; OLIGOMERIZATION; OLIGOMERS; PHOSPHORYLATION; TISSUE;

MOLECULAR BIOLOGY;

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ARTICLE; CELL MEMBRANE; CELL STIMULATION; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME PHOSPHORYLATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERNALIZATION; INTRACELLULAR SIGNALING; LIGAND BINDING; OLIGOMERIZATION; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR OCCUPANCY; RECEPTOR UPREGULATION; STEADY STATE;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ENDOCYTOSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELLS; HEP G2 CELLS; HUMANS; INTRACELLULAR SPACE; LIGANDS; LUMINESCENT PROTEINS; PHOSPHORYLATION; PPAR ALPHA; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; RECEPTORS, ADIPONECTIN; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TIME FACTORS;

EID: 84873324067     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.404624     Document Type: Article

References (56)

1. Rajala, M. W., and Scherer, P. E. (2003) Minireview. The adipocyte. At the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144, 3765-3773
2. Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., and Lodish, H. F. (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746-26749
3. Hu, E., Liang, P., and Spiegelman, B. M. (1996) AdipoQ is a novel adiposespecific gene dysregulated in obesity. J. Biol. Chem. 271, 10697-10703
4. Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., and Matsubara, K. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose most abundant gene transcript 1). Biochem. Biophys. Res. Commun. 221, 286-289
5. Nakano, Y., Tobe, T., Choi-Miura, N. H., Mazda, T., and Tomita, M. (1996) Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem. 120, 803-812
6. Kadowaki, T., and Yamauchi, T. (2005) Adiponectin and adiponectin receptors. Endocr. Rev. 26, 439-451
7. Hui, X., Lam, K. S., Vanhoutte, P. M., and Xu, A. (2012) Adiponectin and cardiovascular health. An update. Br. J. Pharmacol. 165, 574-590
8. Maenhaut, N., and Van De Voorde, J. (2011) Regulation ofvascular tone by adipocytes. BMC Med. 9, 25
9. Ouchi, N., Parker, J. L., Lugus, J. J., and Walsh, K. (2011) Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11, 85-97
10. Xu, A., and Vanhoutte, P. M. (2012) Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 302, H1231-H1240
11. Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., Wade, M. R., Tenorio, V. M., Kuo, M. S., Brozinick, J. T., Zhang, B. B., Birnbaum, M. J., Summers, S. A., and Scherer, P. E. (2011) Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 17, 55-63
12. Chen, X., and Wang, Y. (2011) Adiponectin and breast cancer. Med. Oncol. 28, 1288-1295
13. Dalamaga, M., Diakopoulos, K. N., and Mantzoros, C. S. (2012) The role of adiponectin in cancer. A review of current evidence. Endocr. Rev. 33, 547-594
14. Tsao, T. S., Tomas, E., Murrey, H. E., Hug, C., Lee, D. H., Ruderman, N. B., Heuser, J. E., and Lodish, H. F. (2003) Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J. Biol. Chem. 278, 50810-50817
15. Waki, H., Yamauchi, T., Kamon, J., Kita, S., Ito, Y., Hada, Y., Uchida, S., Tsuchida, A., Takekawa, S., and Kadowaki, T. (2005) Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 146, 790-796
16. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., Murakami, K., Ohteki, T., Uchida, S., Takekawa, S., Waki, H., Tsuno, N. H., Shibata, Y., Terauchi, Y., Froguel, P., Tobe, K., Koyasu, S., Taira, K., Kitamura, T., Shimizu, T., Nagai, R., and Kadowaki, T. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769
17. Buechler, C, Wanninger, J., and Neumeier, M. (2010) Adiponectin receptor binding proteins. Recent advances in elucidating adiponectin signalling pathways. FEBS Lett. 584, 4280-4286
18. Yamauchi, T., Nio, Y, Maki, T, Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M, Kawamoto, S., Kubota, N, Kubota, T., Ito, Y., Kamon, J, Tsuchida, A., Kumagai, K, Kozono, H., Hada, Y, Ogata, H., Tokuyama, K, Tsunoda, M, Ide, T., Murakami, K., Awazawa, M., Takamoto, I., Froguel, P, Hara, K, Tobe, K, Nagai, R., Ueki, K., and Kadowaki, T. (2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med. 13, 332-339
19. Lee, M. H., Klein, R. L., El-Shewy, H. M., Luttrell, D. K., and Luttrell, L. M. (2008) The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth. Biochemistry 47, 11682-11692
20. 2+ and AMPK/SIRT1. Nature 464, 1313-1319
21. 2+/ calmodulindependent protein kinase kinase-dependent pathways. J. Biol. Chem. 284, 22426-22435
22. Heiker, J. T., Wottawah, C. M., Juhl, C, Kosel, D., Morl, K., and Beck-Sickinger, A. G. (2009) Protein kinase CK2 interacts with adiponectin receptor 1 and participates in adiponectin signaling. Cell. Signal. 21, 936-942
23. Hug, C, Wang, J., Ahmad, N. S., Bogan, J. S., Tsao, T. S., and Lodish, H. F. (2004) T-cadherin is a receptor for hexameric and high molecular weight forms of Acrp30/adiponectin. Proc. Natl. Acad. Sci. U. S. A. 101, 10308-10313
24. De Meyts, P. (2008) The insulin receptor. A prototype for dimeric, allosteric membrane receptors? Trends Biochem. Sci. 33, 376-384
25. Vilardaga, J. P., Agnati, L. F., Fuxe, K., and Ciruela, F. (2010) G-proteincoupled receptor heteromer dynamics. J. Cell Sci. 123, 4215-4220
26. Kosel, D., Heiker, J. T., Juhl, C., Wottawah, C. M., Blüher, M., Morl, K., and Beck-Sickinger, A. G. (2010) Dimerization of adiponectin receptor 1 is inhibited by adiponectin. J. Cell Sci. 123, 1320-1328
27. Chen, H., Puhl, H. L., 3rd, Koushik, S. V., Vogel, S. S., and Ikeda, S. R. (2006) Measurement of FRET efficiency and ratio of donor to acceptor concentration in living cells. Biophys. J. 91, L39-L41
28. Feige, J. N, Sage, D., Wahli, W., Desvergne, B., and Gelman, L. (2005) PixFRET, an ImageJ plug-in for FRET calculation that can accommodate variations in spectral bleed-throughs. Microsc. Res. Tech. 68, 51-58
29. Gordon, G. W., Berry, G., Liang, X. H., Levine, B., and Herman, B. (1998) Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy. Biophys. J. 74, 2702-2713
30. Xia, Z., and Liu, Y. (2001) Reliable and global measurement of fluorescence resonance energy transfer using fluorescence microscopes. Biophys. J. 81, 2395-2402
31. Vilardaga, J. P., Bünemann, M., Krasel, C, Castro, M., and Lohse, M. J. (2003) Measurement of the millisecond activation switch of G proteincoupled receptors in living cells. Nat. Biotechnol. 21, 807-812
32. Heyduk, T. (2002) Measuring protein conformational changes by FRET/LRET. Curr. Opin. Biotechnol. 13, 292-296
33. Cheng, Z. J., and Miller, L. J. (2001) Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J. Biol. Chem. 276, 48040-48047
34. Grant, M., Collier, B., and Kumar, U. (2004) Agonist-dependent dissociation of human somatostatin receptor 2 dimers. A role in receptor trafficking. J. Biol. Chem. 279, 36179-36183
35. Pin, J. P., Neubig, R., Bouvier, M., Devi, L., Filizola, M., Javitch, J. A., Lohse, M. J., Milligan, G., Palczewski, K., Parmentier, M., and Spedding, M. (2007) International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. Pharmacol. Rev. 59, 5-13
36. Milligan, G. (2009) G protein-coupled receptor hetero-dimerization. Contribution to pharmacology and function. Br J. Pharmacol. 158, 5-14
37. Rovira, X., Pin, J. P., and Giraldo, J. (2010) The asymmetric/symmetric activation of GPCR dimers as a possible mechanistic rationale for multiple signalling pathways. Trends Pharmacol. Sci. 31, 15-21
38. Bai, M. (2004) Dimerization of G-protein-coupled receptors: roles in signal transduction. Cell. Signal. 16, 175-186
39. Zeug, A., Woehler, A., Neher, E., and Ponimaskin, E. G. (2012) Quantitative intensity-based FRET approaches. A comparative snapshot. Biophys. J. 103, 1821-1827
40. White, J. H., Wise, A., Main, M. J., Green, A., Fraser, N. J., Disney, G. H., Barnes, A. A., Emson, P., Foord, S. M., and Marshall, F. H. (1998) Heterodimerization is required for the formation of a functional GABA (B) receptor. Nature 396, 679-682
41. Margeta-Mitrovic, M., Jan, Y. N, and Jan, L. Y. (2000) A trafficking checkpoint controls GABA (B) receptor heterodimerization. Neuron 27, 97-106
42. Salahpour, A., Angers, S., Mercier, J. F., Lagace, M., Marullo, S., and Bouvier, M. (2004) Homodimerization of the β2-adrenergic receptor as a prerequisite for cell surface targeting. J. Biol. Chem. 279, 33390-33397
43. Herrick-Davis, K., Weaver, B. A., Grinde, E., and Mazurkiewicz, J. E. (2006) Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum. Real-time visualization with confocal fluorescence resonance energy transfer. J. Biol. Chem. 281, 27109-27116
44. Cvejic, S., and Devi, L. A. (1997) Dimerization of the delta opioid receptor. Implication for a role in receptor internalization. J. Biol. Chem. 272, 26959-26964
45. Latif, R., Graves, P., and Davies, T. F. (2002) Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor. J. Biol. Chem. 277, 45059-45067
46. Duran-Prado, M., Malagon, M. M., Gracia-Navarro, F., and Castano, J. P. (2008) Dimerization of G protein-coupled receptors: new avenues for somatostatin receptor signalling, control, and functioning. Mol. Cell. Endocrinol. 286, 63-68
47. O'Dowd, B. F., Ji, X., Alijaniaram, M., Nguyen, T., and George, S. R. (2011) Separation and reformation of cell surface dopamine receptor oligomers visualized in cells. Eur. J. Pharmacol. 658, 74-83
48. Carman, C. V., and Benovic, J. L. (1998) G-protein-coupled receptors. Turn-ons and turn-offs. Curr. Opin. Neurobiol. 8, 335-344
49. Tsao, P., Cao, T., and Von Zastrow, M. (2001) Role of endocytosis in mediating down-regulation of G-protein-coupled receptors. Trends Pharmacol. Sci. 22, 91-96
50. Tsao, P. I., and Von Zastrow, M. (2000) Type-specific sorting of G proteincoupled receptors after endocytosis. J. Biol. Chem. 275, 11130-11140
51. Vu, V., Riddell, M. C, and Sweeney, G. (2007) Circulating adiponectin and adiponectin receptor expression in skeletal muscle. effects of exercise. Diabetes Metab. Res. Rev. 23, 600-611
52. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., Eto, K., Akanuma, Y., Froguel, P., Foufelle, F., Ferre, P., Carling, D., Kimura, S., Nagai, R., Kahn, B. B., and Kadowaki, T. (2002) Adiponectin stimulates glucose utilization and fatty acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288-1295
53. Yamauchi, T., and Kadowaki, T. (2008) Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int. J. Obes. 32, S13-S18
54. Kubota, N, Terauchi, Y., Kubota, T., Kumagai, H., Itoh, S., Satoh, H., Yano, W., Ogata, H., Tokuyama, K., Takamoto, I., Mineyama, T., Ishikawa, M., Moroi, M., Sugi, K., Yamauchi, T., Ueki, K., Tobe, K., Noda, T., Nagai, R., and Kadowaki, T. (2006) Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J. Biol. Chem. 281, 8748-8755
55. Tsuchida, An., Yamauchi, T., Takekawa, S., Hada, Y., Ito, Y., Maki, T., and Kadowaki, T. (2005) Peroxisome proliferator-activated receptor PPARa activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue. Comparison of activation of PPARa, PPAR7, and their combination. Diabetes 54, 3358-3370
56. Narasimhan, M. L., Coca, M. A., Jin, J., Yamauchi, T., Ito, Y., Kadowaki, T., Kim, K. K., Pardo, J. M., Damsz, B., Hasegawa, P. M., Yun, D. J., and Bressan, R. A. (2005) Osmotin is a homolog of mammalian adiponectin and controls apoptosis in yeast through a homolog of mammalian adiponectin receptor. Mol. Cell 17, 171-180